(Q69694601)
Statements
Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641) (English)
Hainsworth JD
Hande KR
Satterlee WG
Kuttesch J
Johnson DH
Grindey G
Jackson LE
1 September 1989